Mallinckrodt LLC, a major manufacturer of oxycodone, agreed to a $35 million settlement with the U.S. Department of Justice and the Drug Enforcement Administration (DEA) for alleged violations of the Controlled Substances Act, according to the agencies.
The company was accused of failing “to meet its obligation to detect and notify” the agencies of suspicious orders for controlled substances and to correctly maintain records requirements at its plant in Hobart, N.Y. The agencies also